Crosstalk of Ras and Rho: activation of RhoA abates Kras-induced liver tumorigenesis in transgenic zebrafish models

RAS and Rho small GTPases are key molecular switches that control cell dynamics, cell growth and tissue development through their distinct signaling pathways. Although much has been learnt about their individual functions in both cell and animal models, the physiological and pathophysiological consequences of their signaling crosstalk in multi-cellular context in vivo remain largely unknown, especially in liver development and liver tumorigenesis. Furthermore, the roles of RhoA in RAS-mediated transformation and their crosstalk in vitro remain highly controversial. When challenged with carcinogens, zebrafish developed liver cancer that resembles the human liver cancer both molecularly and histopathologically. Capitalizing on the growing importance and relevance of zebrafish (Danio rerio) as an alternate cancer model, we have generated liver-specific, Tet-on-inducible transgenic lines expressing oncogenic KrasG12V, RhoA, constitutively active RhoAG14V or dominant-negative RhoAT19N. Double-transgenic lines expressing KrasG12V with one of the three RhoA genes were also generated. Based on quantitative bioimaging and molecular markers for genetic and signaling aberrations, we showed that the induced expression of oncogenic Kras during early development led to liver enlargement and hepatocyte proliferation, associated with elevated Erk phosphorylation, activation of Akt2 and modulation of its two downstream targets, p21Cip and S6 kinase. Such an increase in liver size and Akt2 expression was augmented by dominant-negative RhoAT19N, but was abrogated by the constitutive-active RhoAG14V. Consequently, induced expression of the oncogenic Kras in adult transgenic fish led to the development of hepatocellular carcinomas. Survival studies further revealed that the co-expression of dominant-negative RhoAT19N with oncogenic Kras increased the mortality rate compared with the other single or double-transgenic lines. This study provides evidence of the previously unappreciated signaling crosstalk between Kras and RhoA in regulating liver overgrowth and liver tumorigenesis. Our results also implicate that activating Rho could be beneficial to suppress the Kras-induced liver malignancies.

[1]  D. Stainier,et al.  In vivo cell biology: following the zebrafish trend. , 2006, Trends in cell biology.

[2]  J. Testa,et al.  Perturbations of the AKT signaling pathway in human cancer , 2005, Oncogene.

[3]  K. Kaibuchi,et al.  Rho GTPase/Rho Kinase Negatively Regulates Endothelial Nitric Oxide Synthase Phosphorylation through the Inhibition of Protein Kinase B/Akt in Human Endothelial Cells , 2002, Molecular and Cellular Biology.

[4]  J. Hancock,et al.  Ras proteins: different signals from different locations , 2003, Nature Reviews Molecular Cell Biology.

[5]  Alexander Emelyanov,et al.  Trans-Kingdom Transposition of the Maize Dissociation Element , 2006, Genetics.

[6]  A. Zhu,et al.  The role of signaling pathways in the development and treatment of hepatocellular carcinoma , 2010, Oncogene.

[7]  C. Marshall,et al.  Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 , 1998, Nature.

[8]  Z. Gong,et al.  Modeling Liver Cancer Using Zebrafish: A Comparative Oncogenomics Approach , 2006, Cell cycle.

[9]  H. Pfister,et al.  Cutaneous human papillomaviruses down-regulate AKT1, whereas AKT2 up-regulation and activation associates with tumors. , 2007, Cancer research.

[10]  Edwin Cuppen,et al.  Zebrafish as a Cancer Model , 2008, Molecular Cancer Research.

[11]  M. Wigler,et al.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation , 1996, Molecular and cellular biology.

[12]  C. Der,et al.  Ras history , 2010, Small GTPases.

[13]  B. C. Low,et al.  SmgGDS antagonizes BPGAP1-induced Ras/ERK activation and neuritogenesis in PC12 cell differentiation , 2013, Molecular biology of the cell.

[14]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[15]  M. Taketo,et al.  Hepatocarcinogenesis in mice with beta-catenin and Ha-ras gene mutations. , 2004, Cancer research.

[16]  Z. Gong,et al.  An inducible krasV12 transgenic zebrafish model for liver tumorigenesis and chemical drug screening , 2011, Disease Models & Mechanisms.

[17]  H. Mure,et al.  Akt2 and Akt3 play a pivotal role in malignant gliomas. , 2010, Neuro-oncology.

[18]  J. Prieto,et al.  Transcriptomic effects of Tet-on and mifepristone-inducible systems in mouse liver. , 2008, Human gene therapy.

[19]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[20]  F. Biasi,et al.  Prognostic markers and putative therapeutic targets for hepatocellular carcinoma. , 2010, Molecular aspects of medicine.

[21]  Huiqing Zhan,et al.  Conservation of gene expression signatures between zebrafish and human liver tumors and tumor progression , 2006, Nature Biotechnology.

[22]  M. Mareel,et al.  The new sulindac derivative IND 12 reverses Ras-induced cell transformation. , 2002, Cancer research.

[23]  M. Olson,et al.  Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis. , 2009, European journal of cell biology.

[24]  Thorsten Wohland,et al.  Requirement of vasculogenesis and blood circulation in late stages of liver growth in zebrafish , 2008, BMC Developmental Biology.

[25]  J. Kreisberg,et al.  RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta. , 2002, Cancer research.

[26]  Z. Gong,et al.  RhoA acts downstream of Wnt5 and Wnt11 to regulate convergence and extension movements by involving effectors Rho kinase and Diaphanous: use of zebrafish as an in vivo model for GTPase signaling. , 2006, Cellular signalling.

[27]  F. McCormick,et al.  A role for Rho in Ras transformation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Y. Lee,et al.  Mechanisms by which the inhibition of specific intracellular signaling pathways increase osteoblast proliferation on apatite surfaces. , 2011, Biomaterials.

[29]  James F Amatruda,et al.  Zebrafish as a cancer model system. , 2002, Cancer cell.

[30]  K. Kaibuchi,et al.  Cytoskeletal organization in tropomyosin-mediated reversion of ras-transformation: Evidence for Rho kinase pathway , 2001, Oncogene.

[31]  K. Kaibuchi,et al.  Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation , 1998, Oncogene.

[32]  Z. Gong,et al.  A high level of liver-specific expression of oncogenic KrasV12 drives robust liver tumorigenesis in transgenic zebrafish , 2011, Disease Models & Mechanisms.

[33]  V. Korzh,et al.  RhoA prevents apoptosis during zebrafish embryogenesis through activation of Mek/Erk pathway , 2008, Oncogene.

[34]  D. Tuveson,et al.  Modelling oncogenic Ras/Raf signalling in the mouse. , 2009, Current opinion in genetics & development.

[35]  M. Mandal,et al.  PI3K and Akt as molecular targets for cancer therapy: current clinical outcomes , 2012, Acta Pharmacologica Sinica.

[36]  Jen-Leih Wu,et al.  In vivo studies of liver‐type fatty acid binding protein (L‐FABP) gene expression in liver of transgenic zebrafish (Danio rerio) , 2003, FEBS letters.

[37]  E. Sahai,et al.  Cross‐talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility , 2001, The EMBO journal.

[38]  E. Sahai,et al.  ERK-MAPK signaling coordinately regulates activity of Rac1 and RhoA for tumor cell motility. , 2003, Cancer cell.

[39]  G. Boss,et al.  Oncogenic Ras Leads to Rho Activation by Activating the Mitogen-activated Protein Kinase Pathway and Decreasing Rho-GTPase-activating Protein Activity* , 2003, The Journal of Biological Chemistry.

[40]  B. C. Low,et al.  Using zebrafish for studying Rho GTPases signaling in vivo. , 2012, Methods in molecular biology.

[41]  M. Hung,et al.  Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells , 2001, Nature Cell Biology.

[42]  Y. Tesfaigzi,et al.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer? , 2009, Cell cycle.

[43]  B. Evers,et al.  PI3K/Akt activation is critical for early hepatic regeneration after partial hepatectomy. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[44]  Shinji Tamura,et al.  Expression and prognostic role of RhoA GTPases in hepatocellular carcinoma , 2006, Journal of Cancer Research and Clinical Oncology.

[45]  A. Asthagiri,et al.  Tunable interplay between epidermal growth factor and cell–cell contact governs the spatial dynamics of epithelial growth , 2009, Proceedings of the National Academy of Sciences.

[46]  M. Taketo,et al.  Hepatocarcinogenesis in Mice with β-Catenin and Ha-Ras Gene Mutations , 2004, Cancer Research.

[47]  N. Magnuson,et al.  Pim-1 Kinase-Dependent Phosphorylation of p21Cip1/WAF1 Regulates Its Stability and Cellular Localization in H1299 Cells , 2007, Molecular Cancer Research.

[48]  D. Helfman,et al.  Post-transcriptional down-regulation of ROCKI/Rho-kinase through an MEK-dependent pathway leads to cytoskeleton disruption in Ras-transformed fibroblasts. , 2002, Molecular biology of the cell.

[49]  Yu Li,et al.  Involvement of RhoA in progression of human hepatocellular carcinoma , 2007, Journal of gastroenterology and hepatology.

[50]  C. Der,et al.  Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.

[51]  C. Der,et al.  Dissection of Ras-Dependent Signaling Pathways Controlling Aggressive Tumor Growth of Human Fibrosarcoma Cells: Evidence for a Potential Novel Pathway , 2000, Molecular and Cellular Biology.

[52]  P. Gierschik,et al.  Oncogenic K-Ras down-regulates Rac1 and RhoA activity and enhances migration and invasion of pancreatic carcinoma cells through activation of p38. , 2006, Cellular signalling.

[53]  B. Bai,et al.  Gankyrin plays an essential role in Ras-induced tumorigenesis through regulation of the RhoA/ROCK pathway in mammalian cells. , 2010, The Journal of clinical investigation.

[54]  Z. Gong,et al.  Inducible and repressable oncogene-addicted hepatocellular carcinoma in Tet-on xmrk transgenic zebrafish. , 2012, Journal of hepatology.

[55]  A. Koff,et al.  Rho Activity Can Alter the Translation of p27 mRNA and Is Important for RasV12-induced Transformation in a Manner Dependent on p27 Status* , 2002, The Journal of Biological Chemistry.

[56]  G. Boorman,et al.  Diagnostic Criteria for Degenerative, Inflammatory, Proliferative Nonneoplastic and Neoplastic Liver Lesions in Medaka (Oryzias latipes): Consensus of a National Toxicology Program Pathology Working Group , 1997, Toxicologic pathology.

[57]  Hartmut Land,et al.  Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility , 2007, Nature Structural &Molecular Biology.

[58]  Stefanie Dimmeler,et al.  Akt-Dependent Phosphorylation of p21Cip1 Regulates PCNA Binding and Proliferation of Endothelial Cells , 2001, Molecular and Cellular Biology.

[59]  Julian Downward,et al.  The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer , 2012, Cell.

[60]  M. Monden,et al.  Akt2 expression correlates with prognosis of human hepatocellular carcinoma. , 2004, Oncology reports.

[61]  E. Hanse,et al.  Akt-mediated Liver Growth Promotes Induction of Cyclin E through a Novel Translational Mechanism and a p21-mediated Cell Cycle Arrest* , 2007, Journal of Biological Chemistry.

[62]  J. Ouyang,et al.  Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[63]  W. Yeo,et al.  Targeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. , 2011, Future oncology.

[64]  D. Bar-Sagi,et al.  RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.

[65]  A. Fernández-Medarde,et al.  Ras in cancer and developmental diseases. , 2011, Genes & cancer.

[66]  S. Karlsson,et al.  TGF-β-mediated activation of RhoA signalling is required for efficient V12HaRas and V600EBRAF transformation , 2009, Oncogene.

[67]  Ying Li,et al.  AKT/PKB Phosphorylation of p21Cip/WAF1 Enhances Protein Stability of p21Cip/WAF1 and Promotes Cell Survival* , 2002, The Journal of Biological Chemistry.

[68]  S. Taylor-Robinson,et al.  Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. , 2008, World journal of gastroenterology.

[69]  H. Armelin,et al.  Vasopressin triggers senescence in K-ras transformed cells via RhoA-dependent downregulation of cyclin D1. , 2007, Endocrine-related cancer.

[70]  A. Bounacer,et al.  Opposing effects of mutant ras oncoprotein on human fibroblast and epithelial cell proliferation: implications for models of human tumorigenesis , 2004, Oncogene.

[71]  John G. Collard,et al.  Oncogenic Ras Downregulates Rac Activity, Which Leads to Increased Rho Activity and Epithelial–Mesenchymal Transition , 2000, The Journal of cell biology.

[72]  Z. Gong,et al.  K-ras/PI3K-Akt Signaling Is Essential for Zebrafish Hematopoiesis and Angiogenesis , 2008, PloS one.

[73]  B. Evers,et al.  PKI-587 and sorafenib targeting PI3K/AKT/mTOR and Ras/Raf/MAPK pathways synergistically inhibit HCC cell proliferation. , 2012, The Journal of surgical research.

[74]  Hemant K Roy,et al.  AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis. , 2002, Carcinogenesis.

[75]  J. Lacal,et al.  Rho GTPase expression in tumourigenesis: Evidence for a significant link , 2005, BioEssays : news and reviews in molecular, cellular and developmental biology.

[76]  D. Buhler,et al.  Neoplasia and neoplasm-associated lesions in laboratory colonies of zebrafish emphasizing key influences of diet and aquaculture system design. , 2012, ILAR journal.